SCHEMBL9681067

SCHEMBL9681067

Cc1cccc(N)c1-c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 1/20 0.46
CYP3A4 P08684 6/20 0.43
TDP1 Q9NUW8 3/20 0.43
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
QPCT Q16769 2/20 0.41
TSHR P16473 4/20 0.41
PIK3CA P42336 1/20 0.41
DPP4 P27487 1/20 0.40
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30507348 0.87 MGAM (0.46) CYP3A4MGAMGAASIMGAM2
SCHEMBL25011940 0.87 CD44 (0.54) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL30234670 0.87 CYP3A4 (0.43) CYP3A4TDP1TSHRMAPTALDH1A1
SCHEMBL3789888 0.83 CD44 (0.50) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL9681003 0.83 CD44 (0.50) CD44CYP3A4TDP1GAATSHR
SCHEMBL20522391 0.81 CYP3A4 (0.46) CYP3A4TDP1QPCTTSHRALDH1A1
SCHEMBL3793739 0.80 CYP3A4 (0.54) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL9680722 0.79 SENP1 (0.48) CD44CYP3A4TDP1MGAMGAA
Hydrochloric Acid SCHEMBL9312867 0.78 CYP3A4 (0.58) CD44CYP3A4TDP1TSHRPIK3CA
SCHEMBL2934681 0.78 TSHR (0.43) CYP3A4TDP1TSHRMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed